Verona Pharma plc

("Verona Pharma" or the "Company")

Result of General Meeting 5 January 2012 - London, UK - Verona Pharma plc (AIM: VRP.L), the biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, announces that all of the resolutions put to shareholders at the Company's General Meeting held earlier today were duly passed.

The General Meeting was called pursuant to the notice of general meeting issued to shareholders on 8 December 2011 detailing the Company's proposal to raise approximately
£3.25 million by way of a placing of new shares. Approximately £2.18 million of the gross proceeds were raised within the Company's existing share issuance authorities. The balance of
approximately £1.07 million was conditional, inter alia, upon shareholder approval at the General
Meeting today and admission of the new shares to trading on AIM.
Admission of the new shares to trading on AIM is expected to occur at 8.00 a.m. on 11 January
2012.
-Ends- For more information please contact:

distribué par

Ce noodl a été diffusé par Verona Pharma plc et initialement mise en ligne sur le site http://www.veronapharma.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-05 17:48:13 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.

Documents associés
Result of General Meeting